LISA BROGAN: Open Payments
NPI 1487265013 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,124 in 20 payments from 13 companies in 2025. Trend: 2023 $239 · 2024 $2,223 · 2025 $2,124
Food & beverage: $2,124
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $480 |
| Averitas Pharma Inc. | 4 | $300 |
| Lilly USA, LLC | 2 | $172 |
| Neurocrine BioSciences, Inc. | 1 | $151 |
| Amgen Inc. | 1 | $140 |
| Shionogi Inc | 1 | $124 |
| Boston Scientific Corporation | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| ViiV Healthcare Company | 1 | $115 |
| Sandoz Inc. | 1 | $112 |
Products named: QUTENZA, INGREZZA, KRYSTEXXA, WATCHMAN FLX, TEZSPIRE, KEVZARA, APRETUDE, DUPIXENT.
Industry payments across TX — which companies pay providers there.
